Project Details
Description
A Phase 3, Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Efficacy, Immunogenicity and Safety of 3'aminomethylnicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) as an Aid to Smoking Cessation
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/09 → 3/31/11 |
Funding
- NABI
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.